[1]
A. Khosravi, M.-T. Farzadfard, and A. Abdollahpour, “Frequency of stroke patients qualified for recombinant tissue plasminogen activator (r-TPA) injection and limitations in Zahedan 2016”, Int J Basic Clin Pharmacol, vol. 7, no. 1, pp. 7–10, Dec. 2017.